In vitro and in vivo effects of fulvestrant combined with trastuzumab in breast cancer with estrogen receptor-positive and HER-2/neu-overexpressing

被引：0
|
作者：
Chen, Q. [1 ]
Wu, K. [1 ]
Lu, Y. [1 ]
Ding, L. [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Sch Med, Xin Hua Hosp, Gen Surg, Shanghai 200030, Peoples R China
来源：
EUROPEAN JOURNAL OF CANCER | 2016年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
421
引用
收藏
页码：S121 / S122
页数：2
相关论文
共 50 条
  • [41] Phosphorylated HER-2 tyrosine kinase and Her-2/neu gene amplification as predictive factors of response to trastuzumab in patients with HER-2 overexpressing metastatic breast cancer (MBC)
    Giuliani, Rosa
    Durbecq, Virginie
    Di Leo, Angelo
    Paesmans, Marianne
    Larsimont, Denis
    Leroy, Jean-Yves
    Borms, Marleen
    Vindeuoghel, Anita
    Jerusalem, Guy
    D'Hondt, Veronique
    Dirix, Luc
    Canon, Jean-Luc
    Richard, Vincent
    Cocquyt, Veronique
    Majois, Francoise
    Reginster, Michel
    Demol, Jan
    Kains, Jean-Pierre
    Delree, Paul
    Keppens, Carine
    Sotiriou, Christos
    Piccart, Martine J.
    Cardoso, Fatima
    EUROPEAN JOURNAL OF CANCER, 2007, 43 (04) : 725 - 735
  • [42] Quantitative association between, HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer
    Konecny, G
    Pauletti, G
    Pegram, M
    Untch, M
    Dandekar, S
    Aguilar, Z
    Wilson, C
    Rong, HM
    Bauerfeind, I
    Felber, M
    Wang, HJ
    Beryt, M
    Seshadri, R
    Hepp, H
    Slamon, DJ
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (02) : 142 - 153
  • [43] Pooled peptides from HER-2/neu-overexpressing primary ovarian tumours induce CTL with potent antitumour responses in vitro and in vivo
    A D Gritzapis
    S A Perez
    C N Baxevanis
    M Papamichail
    British Journal of Cancer, 2005, 92 : 72 - 79
  • [44] Serum HER-2/neu levels in clinical studies with lapatinib in HER-2/neu positive breast cancer
    Maltzman, J.
    Blackwell, K.
    Stein, S.
    Martin, A.
    Westland, R.
    Burstein, H.
    Gomez, H.
    Gartner, N.
    Platek, G.
    Newmiller, M.
    Lipton, A.
    Carney, W. P.
    CLINICAL CHEMISTRY, 2008, 54 (06) : A130 - A130
  • [45] Dietary Administration of δ- and γ-Tocopherol Inhibits Tumorigenesis in the Animal Model of Estrogen Receptor-Positive, but not HER-2 Breast Cancer
    Smolarek, Amanda K.
    So, Jae Young
    Burgess, Brenda
    Kong, Ah-Ng Tony
    Reuhl, Kenneth
    Lin, Yong
    Shih, Weichung Joe
    Li, Guangxun
    Lee, Mao-Jung
    Chen, Yu-Kuo
    Yang, Chung S.
    Suh, Nanjoo
    CANCER PREVENTION RESEARCH, 2012, 5 (11) : 1310 - 1320
  • [46] HER-2 expression and response to tamoxifen in estrogen receptor-positive breast cancer: A Southwest Oncology Group Study
    Elledge, RM
    Green, S
    Ciocca, D
    Pugh, R
    Allred, DC
    Clark, GM
    Hill, J
    Ravdin, P
    O'Sullivan, J
    Martino, S
    Osborne, CK
    CLINICAL CANCER RESEARCH, 1998, 4 (01) : 7 - 12
  • [47] Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material
    Xu, RL
    Perle, MA
    Inghirami, G
    Chan, W
    Delgado, Y
    Feiner, H
    MODERN PATHOLOGY, 2002, 15 (02) : 116 - 124
  • [48] The effect of trastuzumab therapy on clinical benefit from fulvestrant treatment for metastatic estrogen receptor-positive breast cancer patients
    Charif, Mahmoud
    Lower, Elyse E.
    Kennedy, Diane
    Kumar, Harriet
    Khan, Shugufta
    Radhakrishnan, Neetu
    Zhang, Xiaoting
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (26)
  • [49] The role of aromatase inhibitors in the management of ductal carcinoma in situ with an estrogen receptor-positive/progesterone receptor-negative/Her-2/neu receptor-positive pattern
    Altundag, Kadri
    Bulut, Nilufer
    Sari, Ebru
    Harputluoglu, Hakan
    AMERICAN JOURNAL OF SURGERY, 2007, 194 (02): : 272 - 273
  • [50] Cost-utility of adjuvant trastuzumab in Her-2/neu positive breast cancer: A Canadian perspective
    Skedgel, C.
    Rayson, D.
    Younis, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345